<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4068188</article-id><article-id pub-id-type="publisher-id">cc13302</article-id><article-id pub-id-type="doi">10.1186/cc13302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Transfusion requirements in septic shock patients: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Bergamin</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Almeida</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Park</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Osawa</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Silva</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Galas</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Nagaoka</surname><given-names>D</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Fukushima</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Vieira</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Candido</surname><given-names>L</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Oshiro</surname><given-names>CO</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A12"><name><surname>Vincent</surname><given-names>JL</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A13"><name><surname>Hajjar</surname><given-names>L</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Instituto do Cancer do Estado de S&#x000e3;o Paulo, Brazil</aff><aff id="I2"><label>2</label>Erasme Hospital, Universit&#x000e9; libre de Bruxelles, Brussels, Belgium</aff><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2014</year></pub-date><volume>18</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">34th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was supported by ISICEM.</named-content></supplement><fpage>P112</fpage><lpage>P112</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Bergamin et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Bergamin et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/18/S1/P112"/><conference><conf-date>18-21 March 2014</conf-date><conf-name>34th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Perioperative red blood cell transfusion is commonly used to address anemia, an independent risk factor for morbidity and mortality in critically ill patients [<xref ref-type="bibr" rid="B1">1</xref>]; however, evidence regarding optimal blood transfusion practice in septic shock is lacking. The aim of this study was to define which is the best transfusion strategy in septic shock patients regarding 28-day mortality and clinical outcomes: restrictive or liberal.</p></sec><sec sec-type="methods"><title>Methods</title><p>The Transfusion Requirements After Cardiac Surgery (TRACS) study is a prospective, randomized, controlled clinical noninferiority trial conducted between February 2009 and February 2010 in an ICU at a university hospital cardiac surgery referral center in Brazil. Consecutive adult patients (<italic>n </italic>= 502) who underwent cardiac surgery with cardiopulmonary bypass were eligible; analysis was by intention to treat.</p><p>This is a randomized controlled parallel-group trial, which included 300 patients admitted to a cancer ICU with diagnosis of septic shock. Patients were randomly assigned to a liberal strategy of blood transfusion (to maintain hemoglobin &#x0003e;9 g/dl) or to a restrictive strategy (hemoglobin &#x0003e;7 g/dl). Mortality in 28 days was the main outcome. Secondary outcomes were clinical complications days free of organ dysfunction, ICU and hospital length of stay, adverse effects of transfusion and 60-day mortality.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 136 patients were included in the first part of the trial. Mean age was 62 &#x000b1; 14 years, SAPS 3 at admission was 65 &#x000b1; 15 and all patients had the diagnosis of solid neoplasm. Sixty-three patients (46.3%) were included in the liberal strategy and 73 patients (53.7%) in the restrictive strategy. Occurrence of 28-day mortality was similar between groups (54% in liberal group vs. 56.2% in restrictive group; <italic>P </italic>= 0.395).</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Among cancer patients with septic shock, the use of a restrictive perioperative transfusion strategy compared with a more liberal strategy resulted in similar rates of 28-day-mortality.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="other"><name><surname>Hajjar</surname><given-names>LA</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Galas</surname><given-names>FR</given-names></name><name><surname>Nakamura</surname><given-names>RE</given-names></name><name><surname>Silva</surname><given-names>CM</given-names></name><name><surname>Santos</surname><given-names>MH</given-names></name><etal/><source>JAMA</source><year>2010</year><volume>304</volume><fpage>1559</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1001/jama.2010.1446</pub-id><pub-id pub-id-type="pmid">20940381</pub-id></mixed-citation></ref></ref-list></back></article>